Because HA levels can shape melanoma cell behaviour, these coordinated changes in HAS–Hyal activity suggest a PACAP-driven shift in ECM dynamics rather than a unidirectional pro- or anti-tumour effect. This evidence concerns the gene ADCYAP1 and melanoma.